Literature DB >> 19096793

Hepatocyte apoptosis.

Mustapha Najimi1, Françoise Smets, Etienne Sokal.   

Abstract

Apoptosis has been documented as a frequent hurdle phenomenon that occurs in human hepatocytes during isolation, storage, infusion and after engraftment within the recipient liver parenchyma. Apoptosis is an active form of cell death that involves programmed cellular machineries leading to a progressive self-destruction of the cell. In contrary to necrosis, it can affect individual cells within a cell population. It is characterized by chronological alteration of intracellular biochemical signaling pathways followed by cellular morphological changes, DNA fragmentation, perturbation of mitochondrial membrane function and changes in the plasma membrane. These cellular alterations can be analyzed using different methodologies on adherent, suspended and in situ engrafted hepatocytes. This chapter presents a brief overview of these techniques and provides methodology for the evaluation of hepatocyte apoptosis at the structural and biochemical levels.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19096793     DOI: 10.1007/978-1-59745-201-4_6

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  8 in total

1.  Caspase-Cleaved Cytokeratin 18 Fragment M30 as a Potential Biomarker of Macrovascular Invasion in Hepatocellular Carcinoma.

Authors:  Hatem Elalfy; Tarek Besheer; Mona M Arafa; Mona Abo-Bakr El-Hussiny; Mahmoud Abd El Latif; Sahar Alsayed Mohamed Alsayed
Journal:  J Gastrointest Cancer       Date:  2018-09

2.  Irreversible electroporation therapy in the liver: longitudinal efficacy studies in a rat model of hepatocellular carcinoma.

Authors:  Yang Guo; Yue Zhang; Rachel Klein; Grace M Nijm; Alan V Sahakian; Reed A Omary; Guang-Yu Yang; Andrew C Larson
Journal:  Cancer Res       Date:  2010-02-02       Impact factor: 12.701

Review 3.  Nuclear functions of the HMG proteins.

Authors:  Raymond Reeves
Journal:  Biochim Biophys Acta       Date:  2009-09-11

4.  Estrogen-Related Receptor γ Agonist DY131 Ameliorates Lipopolysaccharide-Induced Acute Liver Injury.

Authors:  Haoyang Ma; Jiaye Liu; Yang Du; Shengnan Zhang; Weidong Cao; Zhanjun Jia; Wei Gong; Aihua Zhang
Journal:  Front Pharmacol       Date:  2021-04-23       Impact factor: 5.810

5.  Hepatocyte IKK2 protects Mdr2-/- mice from chronic liver failure.

Authors:  Hanno Ehlken; Vangelis Kondylis; Jan Heinrichsdorff; Laura Ochoa-Callejero; Tania Roskams; Manolis Pasparakis
Journal:  PLoS One       Date:  2011-10-14       Impact factor: 3.240

Review 6.  Mitochondrial Mechanisms of Necroptosis in Liver Diseases.

Authors:  Chen Xue; Xinyu Gu; Ganglei Li; Zhengyi Bao; Lanjuan Li
Journal:  Int J Mol Sci       Date:  2020-12-23       Impact factor: 5.923

Review 7.  Human pluripotent stem cells for modelling human liver diseases and cell therapy.

Authors:  Noushin Dianat; Clara Steichen; Ludovic Vallier; Anne Weber; Anne Dubart-Kupperschmitt
Journal:  Curr Gene Ther       Date:  2013-04       Impact factor: 4.391

8.  A positive feedback loop between RIP3 and JNK controls non-alcoholic steatohepatitis.

Authors:  Jérémie Gautheron; Mihael Vucur; Florian Reisinger; David Vargas Cardenas; Christoph Roderburg; Christiane Koppe; Karina Kreggenwinkel; Anne Theres Schneider; Matthias Bartneck; Ulf Peter Neumann; Ali Canbay; Helen Louise Reeves; Mark Luedde; Frank Tacke; Christian Trautwein; Mathias Heikenwalder; Tom Luedde
Journal:  EMBO Mol Med       Date:  2014-08       Impact factor: 12.137

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.